Stock CYCLACEL PHARMACEUTICALS INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Calendar Cyclacel Pharmaceuticals Inc Nasdaq

Equities

US23254L3069

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for Cyclacel Pharmaceuticals Inc
Apr. 01 Cyclacel Pharmaceuticals to Present New Clinical Data at 2024 ASCO Annual Meeting Highlighting Fadraciclib's Potential as a Precision Medicine for Cancer CI
Mar. 19 Transcript : Cyclacel Pharmaceuticals, Inc., Q4 2023 Earnings Call, Mar 19, 2024

Chart calendar Cyclacel Pharmaceuticals Inc

ca7b6e105.SCR3eG88P6JVcac_DWgjob4fwnx9PELWhSO51niiTL8.GkA4CjVxDY8ZHtZKZDsS8PstlSsHaxvktHH7gQzlOvMnYwUpLAkLyycm_g~e7fe04f9ea9e46c9df02a8c05ccd7adf

Upcoming events on Cyclacel Pharmaceuticals Inc

2024-05-07 Q1 2024 Earnings Release (Projected)
2024-05-31 06:30 pm American Society of Clinical Oncology Annual Meeting - Abstract No: 3125
2024-08-06 Q2 2024 Earnings Release (Projected)
2024-11-12 Q3 2024 Earnings Release (Projected)
2025-03-31 Q4 2024 Earnings Release (Projected)

Past events on Cyclacel Pharmaceuticals Inc

2024-04-09 04:30 pm American Association for Cancer Research Meeting - Abstract No: 5711 / 11
2024-04-08 12:00 pm American Association for Cancer Research Meeting - Abstract No: 2117 / 8
2024-04-07 04:30 pm American Association for Cancer Research Meeting - Abstract No: 518 / 15
2024-03-19 04:30 pm Q4 2023 Earnings Call
2024-03-19 04:05 pm Q4 2023 Earnings Release
2024-03-16 Roth Conference
2024-02-26 02:30 pm BIO CEO & Investor Conference
2024-01-08 02:00 pm Biotech Showcase
2023-12-17 Reverse Split: 1 of 15
2023-12-08 09:30 am Extraordinary Shareholders Meeting
2023-11-13 04:30 pm Q3 2023 Earnings Call
2023-11-13 04:05 pm Q3 2023 Earnings Release
2023-08-09 04:30 pm Q2 2023 Earnings Call
2023-08-09 04:05 pm Q2 2023 Earnings Release
2023-06-13 12:00 pm Annual General Meeting
2023-05-11 04:30 pm Q1 2023 Earnings Call
2023-05-11 04:05 pm Q1 2023 Earnings Release
2023-03-13 06:00 pm Roth Conference
2023-03-13 10:00 am Oppenheimer Healthcare Conference
2023-03-06 04:30 pm Q4 2022 Earnings Call

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,42
0,39
7.97%
0,00

EBITDA
Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBIT
Million USD		Released
Forecast
Spread 		-9,68
-9,42
-2.75%		-10,6
-10,2
-4.7%		-22,9
-23,1
0.75%		-27,7
-25,7
-7.71%		-25,5
-26,3
3.24%
-16,3

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-9,13
-8,88
-2.82%		-9,68
-9,25
-4.68%		-22,7
-23,0
1.22%		-25,9
-24,4
-6.29%		-25,6
-26,1
2.17%
-26,5

Net income
Million USD		Released
Forecast
Spread 		-8,03
-7,99
-0.49%		-12,4
-8,41
-47.43%		-19,1
-20,4
6.36%		-21,4
-21,3
-0.4%		-22,8
-23,2
1.72%
-23,7

EPS
USD		Released
Forecast
Spread 		-150
-153
1.96%		-51,3
-38,4
-33.42%		-32,1
-34,6
7.16%		-28,5
-26,7
-6.74%		-26,8
-20,2
-32.25%
-13,4

Announcement Date26/02/2025/02/2128/03/2206/03/2319/03/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,37
0,00
- 		0,02
0,00
- 		0,03
0,00
-
0,00


0,00


0,00


0,00

EBIT
Million USD		Released
Forecast
Spread 		-6,53
-6,71
2.62%		-6,56
-7,15
8.3%		-5,79
-6,98
17.08%		-6,47
-6,79
4.8%		-8,85
-6,94
-27.53%		-7,32
-9,28
21.1%		-5,93
-7,12
16.78%		-6,85
-5,99
-14.3%		-5,36
-6,21
13.73%
-4,54


-4,08


-3,88


-3,76

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-6,49
-6,72
3.37%		-5,25
-7,27
27.88%		-5,56
-7,07
21.4%		-6,11
-6,83
10.5%		-9,00
-6,78
-32.68%		-7,12
-9,29
23.3%		-6,03
-7,26
16.94%		-6,70
-5,82
-15.16%		-5,69
-6,21
8.31%
-6,49


-6,61


-6,72


-6,84

Net income
Million USD		Released
Forecast
Spread 		-5,34
-6,65
19.68%		-4,16
-7,07
41.17%		-4,63
-5,66
18.24%		-5,15
-6,37
19.27%		-7,47
-6,54
-14.15%		-5,85
-8,42
30.43%		-5,50
-6,59
16.63%		-6,15
-5,26
-16.97%		-5,32
-5,70
6.61%
-5,99


-6,11


-6,22


-6,34

EPS
USD		Released
Forecast
Spread 		-8,10
-10,3
21.17%		-6,30
-10,3
38.69%		-6,90
-8,06
14.42%		-6,30
-7,65
17.65%		-9,00
-7,24
-24.35%		-7,05
-9,95
29.15%		-6,60
-7,55
12.58%		-7,35
-5,45
-34.86%		-6,23
-5,89
-5.71%
-4,56


-3,44


-3,20


-2,59

Announcement Date28/03/2211/05/2210/08/2209/11/2206/03/2311/05/2309/08/2313/11/2319/03/24----

Upcoming sector events for Cyclacel Pharmaceuticals Inc

2024-04-23 07:30 am KINIKSA PHARMACEUTICALS, LTD.: Q1 2024 Earnings Release
2024-04-23 INVENTISBIO CO., LIMITED: Q1 2024 Earnings Release (Projected)
2024-04-23 SINOCELLTECH GROUP LIMITED: Q1 2024 Earnings Release (Projected)
2024-04-23 SHANGHAI MEDICILON INC.: Q4 2023 Earnings Release
2024-04-24 04:05 pm VIKING THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-04-24 JIANGSU YAHONG MEDITECH CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-24 BIO-THERA SOLUTIONS, LTD.: Q1 2024 Earnings Release (Projected)
2024-04-24 PTC THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-04-24 REMEGEN CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-24 HITGEN INC.: Q4 2023 Earnings Release
More events

Past sector events for Cyclacel Pharmaceuticals Inc

2024-04-17 BEIJING KAWIN TECHNOLOGY SHARE-HOLDING CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-17 JIANGSU YAHONG MEDITECH CO., LTD.: Q4 2023 Earnings Release
2024-04-12 SINOCELLTECH GROUP LIMITED: Q4 2023 Earnings Release
2024-04-10 07:00 am NURIX THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-04-08 MABWELL (SHANGHAI) BIOSCIENCE CO., LTD.: Q4 2023 Earnings Release
2024-04-02 03:06 am TAIMED BIOLOGICS INC.: March 2024 Sales and Revenue Release
2024-03-31 PEPTRON, INC.: Q4 2023 Earnings Release (Projected)
2024-03-31 BIONEER CORPORATION: Q4 2023 Earnings Release (Projected)
2024-03-29 08:30 am INNOCARE PHARMA LIMITED: Q4 2023 Earnings Release
2024-03-28 BIO-THERA SOLUTIONS, LTD.: Q4 2023 Earnings Release
  1. Stock Market
  2. Equities
  3. CYCC Stock
  4. Stock
  5. Calendar Cyclacel Pharmaceuticals Inc